SV Health Investors
Overview
SV Health Investors is a global private equity and venture capital investment firm exclusively dedicated to the healthcare sector, investing across diverse stages and sub-sectors including biotechnology, healthcare growth equity, and medtech.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AdvanCell | Jul 2026 | Series D | Co-investor |
| Violet Therapeutics | May 2026 | Seed | Co-investor |
| Cerevance | May 2026 | Series C | Co-investor |
| Serenza Therapeutics | May 2026 | Series A | Co-investor |
| Endlyz Therapeutics | May 2026 | Seed | Co-investor |
Key People
Eugene Hill
Managing Partner
Gregory Madden
Managing Partner
Kate Bingham
Managing Partner
Nikola Trbovic
Managing Partner
Tom Flynn
Managing Partner
Ali Jazayeri
Operating Partner
Brett Haumann
Operating Partner
Luke Johnson
Operating Partner
Charles Large
Venture Partner
Forbes Huang
Venture Partner
Hamish Cameron
Venture Partner
Iain Kilty
Venture Partner
Kevin Pojasek
Venture Partner
Luke Devey
Venture Partner
Ravi Rao
Venture Partner
Ruth Mckernan
Venture Partner At SV Health Investors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
